Skip to main content
. 2014 Sep 26;6(9):890–907. doi: 10.4330/wjc.v6.i9.890

Table 3.

Therapeutic approaches in patients with metabolic syndrome

Metabolic syndrome component Goal of therapy Drugs Diet Physical exercise
Arterial hypertension BP < 140/90 mmHg ACEI or ARBs and/ or Ca-antagonists and/ or alpha-blockers1 Limit diuretics and beta-blockers Salt restriction and hypocaloric Regular exercise
Hyperglycemia HbA1c < 7%-6.5% Metformin GLP-1-Agonists DPP-4-inhibitors Hypocaloric Regular exercise
Obesity Weight loss 7%-10% Orlistat Bariatric Surgery Hypocaloric Regular exercise
Dyslipidemia LDL < 100-70 mg/dL TG < 150 mg/dL HDL: Men > 40/ Women > 50 mg/dL Statins ± ezetimibe. PUFA-n-3, Fibrates Hypocaloric Regular exercise
1

Not first choice. BP: Blood pressure; ACEI: Angiotensin converting enzyme inhibithors; ARBs: Angiotensin II receptor blockers; GLP-1: Glucagon-like peptide-1; DPP-4: Dipeptidyl peptidase-4; LDL: Low-density lipoprotein; TG: Triglycerides; HDL: High-density lipoprotein; PUFA-n-3: Omega-3-Polyunsaturated.